DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Cremolini C, Loupakis F, Antoniotti C. et al.
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer.
Lancet Oncol 2015;
16 (13) 1306-1315
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.